A multimodal machine learning model for the stratification of breast cancer risk.

Journal: Nature biomedical engineering
Published Date:

Abstract

Machine learning models for the diagnosis of breast cancer can facilitate the prediction of cancer risk and subsequent patient management among other clinical tasks. For the models to impact clinical practice, they ought to follow standard workflows, help interpret mammography and ultrasound data, evaluate clinical contextual information, handle incomplete data and be validated in prospective settings. Here we report the development and testing of a multimodal model leveraging mammography and ultrasound modules for the stratification of breast cancer risk based on clinical metadata, mammography and trimodal ultrasound (19,360 images of 5,216 breasts) from 5,025 patients with surgically confirmed pathology across medical centres and scanner manufacturers. Compared with the performance of experienced radiologists, the model performed similarly at classifying tumours as benign or malignant and was superior at pathology-level differential diagnosis. With a prospectively collected dataset of 191 breasts from 187 patients, the overall accuracies of the multimodal model and of preliminary pathologist-level assessments of biopsied breast specimens were similar (90.1% vs 92.7%, respectively). Multimodal models may assist diagnosis in oncology.

Authors

  • Xuejun Qian
    Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA.
  • Jing Pei
    1] Center for Brain Inspired Computing Research (CBICR), Department of Precision Instrument, Tsinghua University, Beijing 100084, China [2] Optical Memory National Engineering Research Center, Department of Precision Instrument, Tsinghua University, Beijing 100084, China.
  • Chunguang Han
    Department of Breast Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Zhiying Liang
    School of Biomedical Engineering, ShanghaiTech University, Shanghai, China.
  • Gaosong Zhang
    Department of Ultrasound, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Na Chen
    Department of Rehabilitation Medicine, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China.
  • Weiwei Zheng
    Key Laboratory of the Public Health Safety, Ministry of Education, Department of Environmental Health, School of Public Health, Fudan University, Shanghai, China.
  • Fanlun Meng
    Department of Breast Surgery, Fuyang Cancer Hospital, Fuyang, China.
  • Dongsheng Yu
    School of Electrical and Power Engineering, China University of Mining and Technology, No. 1 Daxue Road, Xuzhou, Jiangsu 221116, China.
  • Yixuan Chen
    Terry Fox Laboratory, BC Cancer Research, Vancouver, British Columbia, Canada.
  • Yiqun Sun
    Department of radiation oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Hanqi Zhang
    Department of Ultrasound, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Wei Qian
    Department of Electrical and Computer Engineering, University of Texas at El Paso, 500 West University Avenue, El Paso, TX 79968, USA; Sino-Dutch Biomedical and Information Engineering School, Northeastern University, No.11, Lane 3, Wenhua Road, Heping District, Shenyang, Liaoning 110819, China. Electronic address: wqian@utep.edu.
  • Xia Wang
    Department of Neurology, The Sixth People's Hospital of Huizhou City, Huizhou, China.
  • Zhuoran Er
    School of Biomedical Engineering, ShanghaiTech University, Shanghai, China.
  • Chenglu Hu
    School of Biomedical Engineering, ShanghaiTech University, Shanghai, China.
  • Hui Zheng
    Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai 200030, China.
  • Dinggang Shen
    School of Biomedical Engineering, ShanghaiTech University, Shanghai, China.